VOR

Vor Biopharma Stock Analysis

AI Rating

Fair
  • Quality1/10
  • Growth↓ 2/10
  • Value↓ 4/10
Vor Biopharma sales and earnings growth
VOR Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -1076.96%
  • FCF Y/Y↓ -44.03%
Vor Biopharma gross and profit margin trends
VOR Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -1228.40%
Vor Biopharma net debt vs free cash flow
VOR Risk
Great
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Vor Biopharma stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗